ABOUT USTHE TEAMPORTFOLIO
Investor RelationsNewsContact usHome
The Xenia partners are a group of star entrepreneurs who have led exits of over $3B.
Virginia Life Science Investments Partnership
Home  /  About Us

ABOUT US

Xenia Venture Capital is an investment company publicly traded in the Tel Aviv Stock Exchange (TASE), operating a technological incubator, and engaged in the initiation and build-up of innovative start up companies in Israel, in the fields of Information Technology and Medical Devices.

Xenia offers a novel vehicle for investment in early stage hi-tech companies. A unique combination of venture capital and a technological incubator - Xenia benefits of government funding for each of its invested companies under the program of privatized incubators of the Ministry of Industry and Trade of the State of Israel ("Pilot Incubators 8.3", see www.incubators.org.il).

In addition to financing, Xenia provides its companies with top-notch mentoring, business and strategic counseling, fund raising assistance and exit planning, as well as basic infrastructure and peripheral services (finance & accounting, logistics, office support, etc), enabling entrepreneurs to operate cost-effectively and to concentrate on advancement of their early stage venture.

Xenia's management team and Board of Directors are comprised of a group of highly-experienced entrepreneurs and business professionals with a proven track record and combined exits of over $3 billion. Xenia also draws on the knowledge and experience of its Advisory Forum, which includes successful entrepreneurs, hi-tech executives, venture capitalists and academics, who actively accompany the portfolio companies and provide them management guidance, advice on developing their business strategies and industry contacts. The Forum also provides valuable input in the screening process of new companies for the incubator.

Since 2004 Xenia has invested in 20 companies, which have attained significant technology and business achievements, resulting in substantial valuation increases. Xenia success rate at incubation maturity currently stands at 90%.

Xenia has also developed excellent deal flow sourcing, selection and execution capabilities, established cooperation relationships with the entrepreneur community as well as with venture capital and high-tech companies in Israel, Europe and the US, and is positioned as a leading incubator in Israel.

Virginia Life Science Investments Partnership
 
Investor RelationsNewsContact us
web design